|
|
|
Management & Administration
OCITS is led by four (4) Principal Investigators ...
Michael Sherar, PhD, University Health Network
Walter Kucharczyk, MD, University Health Network
Randy Ellis, PhD, Queen's University
Terrence Peters, PhD, Robarts Research Institute
... and OCITS has a Scientific Advisory Board of four (4) international experts in image-guided therapy and surgery ...
Dr. S. Morry Blumenfeld, MediTech Advisors, LLC. Israel
Professor David Hawkes, The Guy's, King's and St Thomas' School of Medicine. London, UK
Professor C. Clifton Ling, Memorial Sloan-Kettering Cancer Center, Cornell University. New York, USA
Professor Russell H. Taylor Johns Hopkins University. Maryland, USA
|
Contact Us
|
For more information, please contact:
Mary Wong
OCITS Manager
mwong@uhnres.utoronto.ca
University Health Network
Hydro Place Building, 8F South Rm 8-23
700 University Avenue
Toronto, Ontario M5G 1Z5
416-946-4553 (phone)
416-946-4436 (fax)
|
|
Joy Brusich
OCITS Administrative Coordinator
jbrusich@uhnres.utoronto.ca
|
SAB Profiles
Dr. S. Morry Blumenfeld
is a partner in Meditech Advisors, the general partner of Ziegler Meditech Equity Partners, a private equity fund specializing in medical device
companies which can demonstrate innovative technologies with applications that benefit patients and provide improved patient outcomes. Morry retired from GE Medical
Systems in 2002, having been with GE for over 34 years, the past 27 years with GE Medical Systems, and the last 3 1/2 years as Managing Director of GE Medical
Systems in Israel. He has had considerable experience in developing and commercializing large scale diagnostic imaging systems. Among other accomplishments, Dr.
Blumenfeld was one of the managers responsible for developing GE's computed tomography ("CT") and magnetic resonance imaging ("MRI") product lines, each of which
now have annual sales over $1 billion. He is well known in medical research centers at universities and community hospitals across the USA, in Europe and in Asia
through his work creating the new imaging systems that have revolutionized medicine in the past 30 years. He joined Medical Systems from GE's Research Center in
1975 to initiate GE's CT business, and in the period to 1981 served as Manager of CT Market Development and then as Manager of CT Applications, responsible for
determining the appropriate capabilities and applications which made the GE CT scanners the world's most successful CT systems. In 1981 he became Manager, and in
1983 Product General Manager, for GE's MR business, and in that role successfully directed the development and marketing of GE's Signa MR System to become the
world's most popular MR scanner. During the period 1990-1998, Morry led a "startup" within GE to develop special innovative tools for use in intra-operative imaging of
interventional and minimally invasive surgical procedures. The group also created the first MR guided Focused Ultrasound system and began clinical studies for this
advanced therapy device, which is currently being pursued by Insightec in Israel. He also was responsible during this period for many of the new MR developments,
including advanced cardiac MR and very high field MR systems both now important elements in GE's No.1 market position. Prior to his current position he served as
General Manager, Global Advanced Technology responsible for bringing new technology into all Medical Systems modalities. Morry holds five patents, and in 1977, GE's
Centennial Year, received the GE Centennial Award, and on his retirement from GE Medical Systems he was honored by GE and cited for "...contributions that have
forever changed GE Medical Systems and the field of medical imaging." He has served on the National Cancer Institute Advisory Boards, and on the Imaging Advisory
Committee for the Ontario Government's Research and Development Challenge Fund. He is on the Scientific Advisory Board of the Ontario Consortium for Image-Guided
Therapy and Surgery. He is a member of the Board of Governors of the Hebrew University and also serves on the Board of Directors of Yissum, the Hebrew University's
technology transfer company. He serves on the Boards of several medical device startup companies. Dr. Blumenfeld earned his BASc in Engineering Physics from
University of Toronto, where he also earned an MA and PhD in Molecular Physics.
Email: morry@blumenfeld.com
Prof. David J. Hawkes
has 26 years experience in medical imaging working in both hospital and academic environments. He graduated in Natural Sciences (Physics) form Oxford in 1974 and obtained his PhD in X-ray computed tomography in 1981. He has worked at Southampton General Hospital, Surrey University, the Royal Marsden Hospital and St. George’s Hospital, London, before moving to Guy’s Hospital. Here he founded the Computational Imaging Science Group in 1989 and formed the Medical Imaging Science Interdisciplinary Research Group at the newly merged Guy’s, King’s and St. Thomas’ School of Medicine, King’s College London. Following the restructuring of the KCL School of Medicine in August 2002 he became Chairman of the new Division of Imaging Sciences. His current research interests encompass image matching, data fusion, visualization, shape representation, surface geometry and modeling tissue deformation with applications in image guided interventions, augmented reality in surgery, 3D ultrasound and interventional MRI. He has been on the scientific committees of 32 international meetings and is on the editorial board of 3 journals. He is a member of the EPSRC peer review college, has chaired 2 EPSRC panels in medical engineering and serves on the assessment panel of the DoH Health Technology Devices Programme. Currently he is principal investigator of 7 EPSRC project grants and manager of 3 industrially sponsored projects. He has over 150 publications in the area of medical imaging.
Email: david.hawkes@ucl.ac.uk
Prof. C. Clifton Ling
Email: ling@mpcs.mskcc.org
Prof. Russell H. Taylor
received a B.E.S. degree from The Johns Hopkins University in 1970 and a Ph.D. in Computer Science from Stanford in 1976. He joined IBM Research in 1976, where he developed the AML robot language. Following a two-year assignment in Boca Raton, he managed robotics and automation technology research activities at IBM Research from 1982 until returning to full time technical work in late 1988. From March 1990 to September 1995, he was manager of Computer Assisted Surgery. In September 1995, Dr. Taylor moved to Johns Hopkins University as a Professor of Computer Science, with joint appointments in Surgery, Radiology and Mechanical Engineering. He is also Director of the NSF Engineering Research Center for Computer-Integrated Surgical Systems and Technology. Dr. Taylor has a long history of research in computer-integrated surgery and related fields. In 1988-9, he led the team that developed the first prototype for the ROBODOC© system for robotic hip replacement surgery and is currently on the Scientific Advisory Board of Integrated Surgical Systems. At IBM he subsequently developed novel systems for computer-assisted craniofacial surgery and robotically-augmented endoscopic surgery. At Johns Hopkins, he has worked on all aspects of CIS systems, including modeling, registration, and robotics in areas including percutaneous local therapy, microsurgery, and computer-assisted bone cancer surgery. He is Editor Emeritus of the IEEE Transactions on Robotics and Automation, a Fellow of the IEEE and the AIMBE, and a member of various honorary societies, panels, editorial boards, and program committees. Dr. Taylor is a member of the scientific advisory board for Integrated Surgical Systems. In February 2000 he received the Maurice Müller award for excellence in computer-assisted orthopaedic surgery.
Email: rht@cs.jhu.edu
|
|
